ABOUT US

Grüne Labs, established in Uruguay in 2019, is a pioneering medical cannabis cultivation and production company with a global vision.

We specialize in developing proprietary Cannabis sativa L. genetics, producing high-quality extracts (B2B), and formulating innovative final products (B2C). Our offerings are currently available in Uruguay and Brazil through individual imports, with plans to soon expand distribution to local Brazilian pharmacies.

Our commitment to quality is evident in our adherence to Good Agricultural and Collection Practices (GACP) for cultivation and Good Manufacturing Practice (GMP) standards for extraction and formulation processes.

marcas-ministerio-de-salude-publica-grune-labs-pharmaceutical-laboratory-botanical-technology-2 (1)
marcas-unifam-grune-labs-pharmaceutical-laboratory-botanical-technology-2
marcas-ircca-grune-labs-pharmaceutical-laboratory-botanical-technology-2
marcas-kemia-grune-labs-pharmaceutical-laboratory-botanical-technology-2
Contact Us

GrüneLabs is a global Phytopharmaceutical company with operations in Uruguay, and Portugal.

+598 2291 4543

  • Uruguay
Parque Científico y Tecnológico de Pando
91000, Pando

Departamento de Canelones

  • Portugal

Parque Industrial Gardunha Sul

Estrada Nacional 18, km 80,5

6005-300 | Soalheira

Castelo Branco

Linkedin Facebook Instagram Envelope